Level Bio AB (publ) (NGM:LEVBIO)
0.3740
+0.0860 (29.86%)
At close: Feb 2, 2026
Level Bio AB Market Cap
Level Bio AB has a market cap or net worth of 22.43 million as of February 5, 2026. Its market cap has decreased by -7.87% in one year.
Market Cap
22.43M
Enterprise Value
20.86M
Revenue
30.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.37
Market Cap Chart
Since September 18, 2006, Level Bio AB's market cap has decreased from 35.14M to 22.43M, a decrease of -36.16%. That is a compound annual growth rate of -2.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2026 | 22.43M | 9.33% |
| Dec 30, 2025 | 20.52M | 8.70% |
| Dec 30, 2024 | 18.88M | -27.02% |
| Dec 29, 2023 | 25.87M | -45.31% |
| Dec 30, 2022 | 47.30M | -70.97% |
| Dec 30, 2021 | 162.94M | 142.83% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nexar Group AB | 23.18M |
| Jumpgate AB | 22.61M |
| Kvix AB | 22.44M |
| Trainimal AB | 22.42M |
| Blick Global Group AB | 21.61M |
| LightAir AB | 20.95M |
| Nattaro Labs AB | 20.84M |
| Attana AB | 20.64M |